ABVX is currently riding a wave of bullish momentum, evidenced by a positive MACD trend and a clear path toward the $160 analyst target. While the RSI at 78.87 warns of overbought conditions, the lack of immediate resistance suggests the trend has further room to run. We are ignoring the neutral L1/L2 signals in favor of the momentum and sentiment delta. The trade is a play on the stock's ability to push through $150 and trigger a FOMO-driven rally. We are targeting a quick 3-day window to capitalize on this strength before any mean reversion occurs.

Stop: $131.58 · T1: $164.16 · R:R 1.25

ABVX is showing classic signs of a momentum breakout with elevated volume and a bullish MACD. While the RSI is in the overbought zone, in high-growth biotech, this often signals a strong trend rather than an immediate reversal. With cheap options volatility and analyst targets pointing toward $150, the path of least resistance is currently higher. We are leveraging the low IV to position for a quick spike over the next 72 hours. The trade is a tactical play on strength, aiming for a target extension before any mean reversion occurs.

Stop: $117.32 · T1: $153.28 · R:R 1.25